In 2012 the European Cardiovascular Research Institute (ECRI) was founded as a European collaborative effort to perform Investigator Sponsored Studies in the field of cardiology.
SYNTAX II is a European multicenter single-arm study investigating the effectiveness of a new generation stent ....
TALENT is a prospective multicenter randomized post market all-comer trial to assess the safety and effectiveness of the SUPRAFLEX ...
ECRI provides a structure facilitating trials without the overhead however with the required clinical trial execution expertise.
The GLOBAL LEADERS trial is an Investigator-Sponsored Study (ISS) in which 16,000 “all-comer” patients are enrolled in 131 centers in 18 countries in Europe, Australia, Brazil, Canada & Singapore.
Read more >
A randomized comparison of a rivaroxaban-based strategy with an antiplatelet-based strategy following successful TAVR for the prevention of leaflet thickening and reduced leaflet motion.
Great Britain, Oxford
Oxford University Hospital
Barcelona, Spain
University Hospital Germans Trias i Pujol
Atlanta, Georgia
Piedmont Heart Institute and Cardiovascular Service Line
Rotterdam, The Netherlands
Erasmus University Medical Center,
Rotterdam, The Netherlands
Erasmus University Medical Center
Milan, Italy
IRCCS Policlinico San Donato
Santander, Spain
Hospital Univeristario Marqués de Valdecilla
Rotterdam, The Netherlands
European Cardiovascular Research Institute
Head Department of Cardiology
Thoraxcenter, Erasmus MC
ECRI 2012-2021